DPH Biologicals, a leading biological company formed in 2018, has announced a management-led buyout with a private investment group, while the company will continue to market under the DPH Biologicals brand and continue to provide the same high-quality products and service.
“With proven science, robust field data, strong industry relationships and a focus on biologicals, we are proud of DPH Bio’s robust and profitable growth the past several years. As the biologicals market grows, we believe farmers and producers around the world will increasingly demand biological products that work within existing management practices and offer multiple bottom-line benefits, beyond yield,” said Mick Messman, DPH Bio president and CEO.
The full management team brings decades of experience in agricultural sales, marketing, research, product development, supply chain management and business strategy, both domestically and internationally, and led the company’s rapid scale up and product portfolio expansion, building upon its flagship product – TerraTrove® SP-1®. The DPH Bio management team includes Mick Messman, Alex Cochran, Chris Feiden, Trey Soud, Brad Holzworth, Roberto Werneck and Cliff Watrin, and Mario Tenerelli as Latin America advisor.
“Our team has demonstrated business success in the ag industry and a commitment to deliver value to farmers. We saw the need for a company focused on developing and scaling biological technologies and began the transformation of DPH Bio in mid-2021. When ownership discussions started last year, the existing management team decided the time was right and we were ready and willing to fully invest in the company ourselves,” Messman said.
With teams based in Indianapolis, Ind. and Princeton, Ill., and territory managers located in key markets, Messman adds that DPH Bio will continue bringing its diverse and growing product line to customers around the world, including planned expansion into Brazil.
Visit www.dphbio.com for more information.